ITC Favors Medytox over Daewoong in Botulinum Toxin Strain Dispute in Final Ruling

SEOUL, Dec. 17 (Korea Bizwire) — A U.S. trade panel has upheld its preliminary ruling by siding with South Korean drugmaker Medytox Inc. in a trade dispute, saying its local rival Daewoong Pharmaceutical Co. copied the manufacturing process of a botulinum toxin strain, industry officials here said Thursday. In a final decision, the U.S. International [...]